Sialic acids and the metabolism of low density lipoprotein

Journal of Lipid Research

Volumn 37, Issue 8, 1996, Pages 1625-1631

  Melajärvi, Nina ^a   Gylling, Helena ^a   Miettinen, Tatu A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

apolipoprotein B; coronary artery disease; LDL cholesterol; LDL kinetics; non insulin dependent diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; APOLIPOPROTEIN B; GLIBENCLAMIDE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SIALIC ACID; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CATABOLISM; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAM; EXERCISE TEST; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; METABOLIC RATE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEINS B; BLOOD SPECIMEN COLLECTION; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; HUMANS; KINETICS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; N-ACETYLNEURAMINIC ACID; REFERENCE VALUES;

EID: 0029790419     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Stryer, L. 1988. Biochemistry. 3rd ed. W. H. Freeman and Co., New York. 331-348, 547-574.
2. Tertov, V. V., I. A. Sobenin, Z. A. Gabbasov, E. G. Popov, and A. N. Orekhov. 1989. Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins. Biochem. Biophys. Res. Commun. 163: 489-494.
3. Orekhov, A. N., V. V. Tertov, S. N. Pokrovsky, I. Y. Adamova, O. N. Martsenyuk, A. A. Lyakishev, and V. N. Smirnov. 1988. Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination. Circ. Res. 62: 421-429.
4. Orekhov, A. N., V. V. Tertov, and D. N. Mukhin. 1991. Desialylated low density lipoprotein naturally occurring modified lipoprotein with atherogenic potency. Atherosclerosis. 86: 153-161.
5. Orekhov, A. N., V. V. Tertov, I. A. Sobenin, V. N. Smirnov, D. P. Via, J. Guevara, Jr., A. M. Gotto, Jr., and J. D. Morrisett. 1992. Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. J. Lipid Res. 33: 805-817.
6. Tertov, V. V., A. N. Orekhov, I. A. Sobenin, J. D. Morrisett, A. M. Gotto, Jr., and J. G. Guevara, Jr. 1993. Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease. J. Lipid Res. 34: 365-375.
7. Jaakkola, O., T. Solakivi, V. V. Tertov, A. N. Orekhov, T. A. Miettinen, and T. Nikkari. 1993. Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease. Coronary Artery Dis. 4: 379-385.
8. Ruelland, A., G. Gallou, B. Legras, F. Paillard, and L. Cloarec. 1993. LDL sialic acid content in patients with coronary artery disease. Clin. Chim. Acta. 221: 127-133.
9. La Belle, M., and R. M. Krauss. 1990. Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns. J. Lipid Res. 31: 1577-1588.
10. Sobenin, I. A., V. V. Tertov, T. Koschinsky, C. E. Bunting, E. S. Slavina, I. I. Dedov, and A. N. Orekhov. 1993. Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimai aortic cells. Atherosclerosis. 100: 41-54.
11. Chappey, B., I. Myara, P. Giral, G. Kerharo, M. C. Plainfosse, J. Levenson, A. Simon, N. Moatti, and the PCVMETRA Group. 1995. Evaluation of the sialic acid content of LDL as a marker of coronary calcification and extracoronary atherosclerosis in asymptomatic hypercholesterolemic subjects. Arterioscler. Thromb. Vasc. Biol. 15: 334-339.
12. Shireman, R. B., and W. R. Fisher. 1979. The absence of a role for the carbohydrate moiety in the binding of apolipoprotein B to the low density lipoprotein receptor. Biochim. Biophys. Acta. 572: 537-540.
13. Goldstein, J. L., and M. S. Brown. 1989. Familial hypercholesterolemia. In The Metabolic Basis of Inherited Disease. 6th ed. C. K. Scriver, A. L. Beaudet, W. S. Sly and D. Valle, editors. McGraw Hill, Inc., New York. 1215-1250.
14. Miettinen, T., and I-T. Takki-Luukkainen. 1959. Use of butyl acetate in determination of sialic acid. Acta Chem. Scand. 13: 856-858.
15. Svennerholm, L. 1957. Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim. Biophys. Acta. 24: 604-611.
16. Warren, L. 1959. The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 234: 1971-1975.
17. Lipid Research Clinics Program. 1974. Manual of Laboratory Operations. Lipids and Lipoprotein Analysis. National Institutes of Health. DHEW Publication No. (NIH) 75-628. Bethesda, MD. 1: 51-59.
18. Gylling, H., H. Vanhanen, and T. A. Miettinen. 1993. Effects of ketoconazole on cholesterol precursors and low density lipoprotein kinetics in hypercholesterolemia. J. Lipid Res. 34: 59-67.
19. McFarlane, A. S. 1958. Efficient trace-labelling of proteins with iodine. Nature. 182: 53-57.
20. Bilheimer, D. W., S. Eisenberg, and R. I. Levy. 1972. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim. Biophys. Acta. 260: 212-221.
21. Esterbauer, H., G. Striegl, H. Puhl, and M. Rotheneder. 1989. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Commun. 6: 67-75.
22. 131I-labeled plasma proteins. Phys. Med. Biol. 2:36-53.
23. Lindberg, G., G. A. Eklund, B. Gullberg, and L. Råstam. 1991. Serum sialic acid concentration and cardiovascular mortality. Br. Med. J. 302: 143-146.
24. Wakabayashi, I., K. Sakamoto, S. Yoshimoto, and H. Masui. 1992. Relation of serum sialic acid to lipid concentrations. Br. Med. J. 305: 562-563.
25. Watts, G. F., M. A. Crook, S. Haq, and S. Mandalia. 1995. Serum sialic acid as an indicator of change in coronary artery disease. Metabolism. 44: 147-148.
26. Austin, M. A., J. L. Breslow, C. H. Hennekens, J. E. Buring, W. C. Willett, and R. M. Krauss. 1988. Low-density lipoprotein subclass patterns and risk of myocardial infarction. J. Am. Med. Assoc. 260: 1917-1921.
27. Vega, G. L., and S. M. Grundy. 1989. Studies on mechanisms for enhanced clearance of low-density lipoproteins in patients with primary hypertriglyceridemia. J. Int. Med. 226: 5-15.
28. Swaminathan, N., and F. Aladjem. 1974. The carbohydrate moiety of human serum low density lipoproteins. Fed. Proc. 33: 1585.
29. Miettinen, T. A., H. Gylling, H. Vanhanen, and A. Ollus. 1992. Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arterioscler. Thromb. 12: 1044-1052.
30. Gylling, H., and T. A. Miettinen. 1992. Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypes. J. Lipid Res. 33: 1361-1371.